应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
LEGN 传奇生物
盘后交易 04-21 18:00:07 EDT
32.24
-0.56
-1.71%
盘后
32.24
+0.00
0.00%
16:05 EDT
最高
32.98
最低
32.02
成交量
72.43万
今开
32.55
昨收
32.80
日振幅
2.93%
总市值
59.21亿
流通市值
26.11亿
总股本
1.84亿
成交额
2,345万
换手率
0.89%
流通股本
8,099万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
传奇生物4月17日成交额为5926.58万美元
市场透视 · 04-18
传奇生物4月17日成交额为5926.58万美元
传奇生物CAR-T一季度收入3.69亿美金；赛诺菲OX40L单抗哮喘II期研究失败
Ofweek光电信息网 · 04-16
传奇生物CAR-T一季度收入3.69亿美金；赛诺菲OX40L单抗哮喘II期研究失败
传奇生物4月15日成交额为1.51亿美元
市场透视 · 04-16
传奇生物4月15日成交额为1.51亿美元
美股异动 | 传奇生物(LEGN.US)涨近6% 专注于开发新型细胞疗法
智通财经 · 04-15
美股异动 | 传奇生物(LEGN.US)涨近6% 专注于开发新型细胞疗法
拼多多等27只中概股有望回流香港，市值超万亿
sina · 04-15
拼多多等27只中概股有望回流香港，市值超万亿
Legend Biotech 2024年第四季度调整后每股收益$(0.16)优于预期$(0.33)，销售额$1.8652亿优于预期$1.7893亿
财报速递 · 03-11
Legend Biotech 2024年第四季度调整后每股收益$(0.16)优于预期$(0.33)，销售额$1.8652亿优于预期$1.7893亿
传奇生物盘中异动 急速下挫5.11%报33.22美元
市场透视 · 03-03
传奇生物盘中异动 急速下挫5.11%报33.22美元
传奇生物盘中异动 股价大跌5.04%报34.87美元
市场透视 · 02-28
传奇生物盘中异动 股价大跌5.04%报34.87美元
传奇生物盘中异动 股价大跌5.04%报37.70美元
市场透视 · 02-24
传奇生物盘中异动 股价大跌5.04%报37.70美元
首次一窥：《万智牌~最终幻想》
美通社 · 02-19
首次一窥：《万智牌~最终幻想》
传奇生物盘中异动 早盘快速拉升5.24%报38.33美元
市场透视 · 02-18
传奇生物盘中异动 早盘快速拉升5.24%报38.33美元
交银国际：维持金斯瑞生物科技“买入”评级 目标价28.75港元
新浪网 · 02-18
交银国际：维持金斯瑞生物科技“买入”评级 目标价28.75港元
金十数据整理：每日港股市场要闻速递（2月18日 周二）
美港电讯 · 02-18
金十数据整理：每日港股市场要闻速递（2月18日 周二）
传奇生物不再并表后 金斯瑞预计2024年业绩大增
第一财经 · 02-17
传奇生物不再并表后 金斯瑞预计2024年业绩大增
金斯瑞生物科技盈喜：预计年度净利润较同期有重大增长
格隆汇 · 02-16
金斯瑞生物科技盈喜：预计年度净利润较同期有重大增长
高瓴旗下HHLR Advisors披露四季度美股持仓 前十大重仓中概股占8席
美港电讯 · 02-15
高瓴旗下HHLR Advisors披露四季度美股持仓 前十大重仓中概股占8席
【高瓴旗下HHLR Advisors披露四季度美股持仓 前十大重仓中概股占8席】高瓴旗下独立的、专注于二级市场投资的基金管理平台HHLR Advisors公布了截至2024年四季度末的美股持仓数据。数据显示，四季度HHLR Advisors前十大持仓中，中概股占据八席。百济神州、阿里巴巴仍为前两大重仓股，此外还有拼多多、网易、贝壳、唯品会、传奇生物和富途控股。持仓情况显示出HHLR Advisors对中国资产的持续聚焦。在HHLR Advisors四季度新进买入的4只股票中，2只为中概股，分别为声网和挚文集团（陌陌）。四季度HHLR Advisors增持了10只股票，其中4只为中概股，为京东、贝壳、富途控股和达达集团。
金融界 · 02-14
【高瓴旗下HHLR Advisors披露四季度美股持仓 前十大重仓中概股占8席】高瓴旗下独立的、专注于二级市场投资的基金管理平台HHLR Advisors公布了截至2024年四季度末的美股持仓数据。数据显示，四季度HHLR Advisors前十大持仓中，中概股占据八席。百济神州、阿里巴巴仍为前两大重仓股，此外还有拼多多、网易、贝壳、唯品会、传奇生物和富途控股。持仓情况显示出HHLR Advisors对中国资产的持续聚焦。在HHLR Advisors四季度新进买入的4只股票中，2只为中概股，分别为声网和挚文集团（陌陌）。四季度HHLR Advisors增持了10只股票，其中4只为中概股，为京东、贝壳、富途控股和达达集团。
传奇生物盘中异动 股价大跌5.24%
市场透视 · 02-06
传奇生物盘中异动 股价大跌5.24%
传奇生物盘中异动 早盘股价大涨5.15%报39.23美元
市场透视 · 02-04
传奇生物盘中异动 早盘股价大涨5.15%报39.23美元
传奇生物Carvykti大卖 9.63 亿美元：细胞治疗未来已来，如何解决普及难题？
21财经 · 01-24
传奇生物Carvykti大卖 9.63 亿美元：细胞治疗未来已来，如何解决普及难题？
加载更多
公司概况
公司名称：
传奇生物
所属市场：
NASDAQ
上市日期：
--
主营业务：
传奇生物科技有限公司是一家全球性的临床级生物制药公司，致力于肿瘤和其他适应症的新药的发现和开发。该公司的差异化技术、全球开发和制造战略及专业知识使其能够针对高未满足需求的适应症生成、测试和制造下一代细胞疗法。
发行价格：
--
{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"传奇生物","latestPrice":32.24,"timestamp":1745265600000,"preClose":32.8,"halted":0,"volume":724273,"hourTrading":{"tag":"盘后","latestPrice":32.24,"preClose":32.24,"latestTime":"16:05 EDT","volume":8491,"amount":273749.84,"timestamp":1745265912711},"delay":0,"floatShares":80994144,"shares":183649157,"eps":-0.968143,"marketStatus":"盘后交易","change":-0.56,"latestTime":"04-21 18:00:07 EDT","open":32.55,"high":32.98,"low":32.02,"amount":23445838.184604,"amplitude":0.029268,"askPrice":32.9,"askSize":100,"bidPrice":30.43,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.968143,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":32.8,"postHourTrading":{"tag":"盘后","latestPrice":32.24,"preClose":32.24,"latestTime":"16:05 EDT","volume":8491,"amount":273749.84,"timestamp":1745265912711},"volumeRatio":0.306718,"impliedVol":0.588,"impliedVolPercentile":0.476},"requestUrl":"/m/hq/s/LEGN","defaultTab":"news","newsList":[{"id":"2528707644","title":"传奇生物4月17日成交额为5926.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528707644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528707644?lang=zh_cn&edition=full","pubTime":"2025-04-18 09:51","pubTimestamp":1744941084,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，传奇生物成交额为5926.58万美元，成交额较昨日减少31.28%，当日成交量为181.28万股。传奇生物于2025年4月17日跌1.97%，报32.8美元，该股过去5个交易日涨4.86%，年初至今涨0.8%，过去60日跌12.39%。该公司的主要候选产品LCAR-B38M/JNJ-4528是一种用于治疗多发性骨髓瘤的嵌合抗原受体或CAR- T细胞疗法。该公司的收入来自许可证和协作收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095125a6beaec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418095125a6beaec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LEGN","BK4139","BK4585","BK4505"],"gpt_icon":0},{"id":"2527423484","title":"传奇生物CAR-T一季度收入3.69亿美金；赛诺菲OX40L单抗哮喘II期研究失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2527423484","media":"Ofweek光电信息网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527423484?lang=zh_cn&edition=full","pubTime":"2025-04-16 13:51","pubTimestamp":1744782660,"startTime":"0","endTime":"0","summary":"根据强生财报，传奇生物CAR-T一季度收入3.69亿美金，继续大卖。赛诺菲运气不佳。4月15日，赛诺菲宣布，OX40L单抗Amlitelimab治疗哮喘的II期TIDE-Asthma研究未达到主要终点。该药物的哮喘III期研究计划正在规划中。3）强生一季度销售额218.9亿美元4月15日，强生发布一季报。第一季度销售额218.9亿美元，预估215.8亿美元；第一季度药品收入138.7亿美元，预估134.3亿美元。强生预计全年销售额910亿美元至918亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041614022894d7073b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041614022894d7073b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4230","BK4139","BK4588","BK4505","CAR","BK4585","BK4022","LEGN"],"gpt_icon":0},{"id":"2527407032","title":"传奇生物4月15日成交额为1.51亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527407032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527407032?lang=zh_cn&edition=full","pubTime":"2025-04-16 09:46","pubTimestamp":1744767992,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日，传奇生物成交额为1.51亿美元，成交额较昨日增加259.28%，当日成交量为444.75万股。传奇生物于2025年4月15日涨5.08%，报33.74美元，该股过去5个交易日涨9.65%，年初至今涨3.69%，过去60日涨3.31%。该公司的主要候选产品LCAR-B38M/JNJ-4528是一种用于治疗多发性骨髓瘤的嵌合抗原受体或CAR- T细胞疗法。该公司的收入来自许可证和协作收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416094642a6bbea68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416094642a6bbea68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LEGN","BK4139","BK4505","BK4588"],"gpt_icon":0},{"id":"2527442414","title":"美股异动 | 传奇生物(LEGN.US)涨近6% 专注于开发新型细胞疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2527442414","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527442414?lang=zh_cn&edition=full","pubTime":"2025-04-15 23:57","pubTimestamp":1744732621,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，传奇生物(LEGN.US)涨近6%，报34.02美元。据悉，传奇生物是一家全球性临床阶段生物制药公司，专注于开发新型细胞疗法，尤其在肿瘤学领域具有领先地位。公司成立于2015年，总部位于开曼群岛，并在美国、中国等地设有分支机构。其核心产品为CAR-T疗法 CARVYKTI®(西达基奥仑赛)，用于治疗多发性骨髓瘤(MM)，与强生旗下杨森公司(Janssen)合作研发和商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4588","BK4505","BK4585","LEGN"],"gpt_icon":0},{"id":"1188020974","title":"拼多多等27只中概股有望回流香港，市值超万亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1188020974","media":"sina","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188020974?lang=zh_cn&edition=full","pubTime":"2025-04-15 11:46","pubTimestamp":1744688813,"startTime":"0","endTime":"0","summary":"中国香港市场成为中概股回流的主要市场。哪些中概股有望回港上市？据香港交易所最新的上市要求，高盛估计有27只、总市值达1.35万亿元人民币的中概股，或将有资格在香港进行双重主要上市或第二上市。对于本轮可能的中概股回流潮影响，瑞银估计，目前约有230只在美上市的中概股，在美国的总市值敞口为4600亿美元，低于2021年底的1.1万亿美元。2021年及2022年曾出现除牌恐慌并导致中概股平均下跌22%，预期本次影响情况更为可控。","market":"hk","thumbnail":"https://static.tigerbbs.com/a796e187cd68ff5211b52cff6a06ca1b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a796e187cd68ff5211b52cff6a06ca1b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-04-14/doc-inetcqhp8231675.shtml","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1696758196214","symbols":["LEGN","YMM","ZK","VIPS","PDD"],"gpt_icon":1},{"id":"1136475985","title":"Legend Biotech 2024年第四季度调整后每股收益$(0.16)优于预期$(0.33)，销售额$1.8652亿优于预期$1.7893亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1136475985","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136475985?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:01","pubTimestamp":1741694476,"startTime":"0","endTime":"0","summary":"Legend Biotech 公布季度每股亏损为$，优于分析师一致预期的$，超出51.52%。与去年同期的销售额$7946万相比，提高了134.73%。以上内容来自Benzinga Earnings专栏，原文如下：Legend Biotech reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 51.52 percent. This is a 33.33 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $186.52 million which beat the analyst consensus estimate of $178.93 million by 4.24 percent. This is a 134.73 percent increase over sal","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Legend Biotech 2024年第四季度调整后每股收益$(0.16)优于预期$(0.33)，销售额$1.8652亿优于预期$1.7893亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN"],"gpt_icon":0},{"id":"2516657480","title":"传奇生物盘中异动 急速下挫5.11%报33.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516657480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516657480?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:19","pubTimestamp":1741029571,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时19分，传奇生物股票出现异动，股价急速下跌5.11%。截至发稿，该股报33.22美元/股，成交量51.7461万股，换手率0.28%，振幅6.34%。传奇生物股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4516.48%、204.98%、180.78%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。该公司的收入来自许可证和协作收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304031931a25d8fca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304031931a25d8fca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LEGN","BK4139","BK4505","BK4588"],"gpt_icon":0},{"id":"2516837032","title":"传奇生物盘中异动 股价大跌5.04%报34.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516837032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516837032?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:00","pubTimestamp":1740765604,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时00分，传奇生物股票出现异动，股价急速下挫5.04%。截至发稿，该股报34.87美元/股，成交量66.1794万股，换手率0.36%，振幅3.57%。传奇生物股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3148.47%、516.95%、375.72%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.50%、48.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010200049896a911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010200049896a911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEGN","BK4505","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2514779602","title":"传奇生物盘中异动 股价大跌5.04%报37.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514779602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514779602?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:50","pubTimestamp":1740415837,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时50分，传奇生物股票出现异动，股价急速下跌5.04%。截至发稿，该股报37.70美元/股，成交量100.457万股，换手率0.55%，振幅4.74%。传奇生物股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为278.63%、117.82%、35.63%，振幅较大的相关个股有Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 、Telix Pharmaceutic，振幅分别为162.04%、81.92%、55.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022500503798911475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022500503798911475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4585","LEGN","BK4588"],"gpt_icon":0},{"id":"2512147245","title":"首次一窥：《万智牌~最终幻想》","url":"https://stock-news.laohu8.com/highlight/detail?id=2512147245","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512147245?lang=zh_cn&edition=full","pubTime":"2025-02-19 11:33","pubTimestamp":1739935980,"startTime":"0","endTime":"0","summary":"《万智牌~最终幻想》融合了一系列独特的机制与内容，灵感源自于全球粉丝所钟爱的丰富世界与震撼人心的生物。更多惊喜待揭晓：《万智牌~最终幻想》系列中还有许多特殊机制尚未公布，更多精彩内容值得期待。此外，威世智公司还将在陆续分享关于《万智牌~最终幻想》特别假日发布的更多信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4622378_ZH22378_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4585","BK4566","BK4190","BK4505","LEGN","BK4588","BK4139","HAS"],"gpt_icon":0},{"id":"2512165922","title":"传奇生物盘中异动 早盘快速拉升5.24%报38.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165922?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:43","pubTimestamp":1739889823,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时43分，传奇生物股票出现异动，股价快速拉升5.24%。截至发稿，该股报38.33美元/股，成交量8.3711万股，换手率0.05%，振幅3.90%。机构评级方面，在所有27家参与评级的机构中，93%的券商给予买入建议，7%的券商给予持有建议，无券商给予卖出建议。传奇生物股票所在的生物技术行业中，整体涨幅为0.60%。该信息摘要如下：交银国际发布报告称，看好金斯瑞生物科技估值修复的巨大空间，维持“买入”评级和28.75港元目标价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182243439889ff6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182243439889ff6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LEGN","BK4139","BK4505","BK4588"],"gpt_icon":0},{"id":"2512137799","title":"交银国际：维持金斯瑞生物科技“买入”评级 目标价28.75港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512137799","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512137799?lang=zh_cn&edition=full","pubTime":"2025-02-18 17:40","pubTimestamp":1739871605,"startTime":"0","endTime":"0","summary":"交银国际发布报告称，看好金斯瑞生物科技估值修复的巨大空间，维持“买入”评级和28.75港元目标价。从净利润层面，2024年起集团将全面进入盈利区间，2024年净利润相较2023年将大幅增长。该行称，情绪面上，地缘因素相关短期扰动逐步出清、创新药支付利好政策落地和优秀创新药资产加速出海，有望催化CXO板块投资情绪企底回升。扣除上述两项影响后，公司2024年非细胞业务的经调整净利润相较2023年保持稳定，未发生重大变化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021818113796275a0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021818113796275a0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEGN","01548"],"gpt_icon":0},{"id":"2512305908","title":"金十数据整理：每日港股市场要闻速递（2月18日 周二）","url":"https://stock-news.laohu8.com/highlight/detail?id=2512305908","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512305908?lang=zh_cn&edition=full","pubTime":"2025-02-18 09:00","pubTimestamp":1739840427,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["00753","BK0196","HK0000320223.HKD","BK1123","BK1505","BK4505","CFA.SI","LEGN","601628","LU0588546209.SGD","601111","LU0307460666.USD","BK0207","BK4585","BK1096","02533","BK1514","BK4139","BK0280","00670","02217","BK1561","BK1521","HK0000306685.HKD","HK0000320264.USD","BK0012","YANG","LU0287142896.SGD","BK1141","BK1184","BK1557","BK0183","BK1550","09636","LU0173614495.USD","BK0006","HSCEI","07226","01548","SG9999012736.USD","BK0028","BK0188","BK0010","HSTECH","BK1583","CFA","01070","BK1131","BK4588","02628"],"gpt_icon":0},{"id":"2512917160","title":"传奇生物不再并表后 金斯瑞预计2024年业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2512917160","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512917160?lang=zh_cn&edition=full","pubTime":"2025-02-17 17:13","pubTimestamp":1739783580,"startTime":"0","endTime":"0","summary":"2月16日晚间，金斯瑞发布了正面盈利公告，公司预计2024年录得的净利润有重大增长。因此，金斯瑞对传奇生物的投票权行使权，从原来超过50%变为低于50%。不过，传奇生物尚未扭亏为盈，这对金斯瑞业绩是一种承压。传奇生物财务数据不再并入金斯瑞后，而重新被金斯瑞分类为重要联营公司。根据金斯瑞此次发布的业绩预告，这次的会计处理，可以一次性给公司贡献32亿美元收益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021717150398886ec6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021717150398886ec6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","LEGN","BK4588","BK4505","01548"],"gpt_icon":0},{"id":"2511252939","title":"金斯瑞生物科技盈喜：预计年度净利润较同期有重大增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2511252939","media":"格隆汇","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511252939?lang=zh_cn&edition=full","pubTime":"2025-02-16 18:35","pubTimestamp":1739702153,"startTime":"0","endTime":"0","summary":"格隆汇2月16日丨金斯瑞生物科技公布，集团预期截至2024年12月31日止年度录得的净利润较截至2023年12月31日止年度有重大增长。于报告期内，公司将解除合并前传奇生物的税后亏损录为非持续经营业绩；解除合并后使用权益法录得所占传奇生物的损益份额。从非细胞疗法业务角度，及剔除以上和两项影响后，报告期内经调整净利润保持稳定，较上期未发生重大变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216183554abd0ec39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216183554abd0ec39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"金斯瑞生物科技盈喜：预计年度净利润较同期有重大增长","news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEGN","01548"],"gpt_icon":0},{"id":"2511564175","title":"高瓴旗下HHLR Advisors披露四季度美股持仓 前十大重仓中概股占8席","url":"https://stock-news.laohu8.com/highlight/detail?id=2511564175","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511564175?lang=zh_cn&edition=full","pubTime":"2025-02-15 08:24","pubTimestamp":1739579072,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2971e183654e014f9d8fb02ec3bea877","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["SG9999001903.USD","LU0630378429.USD","688235","MOMO","LU2279701549.SGD","LU0791591158.USD","TTTN","BABA","89618","09999","TCOM","LEGN","SG9999001093.SGD","JD","SG9999011746.SGD","HK0000306685.HKD","LU1823568750.SGD","LU0106959298.USD","SOHU","09961","LU0359202008.SGD","LU0630378692.HKD","IE00BPRC5H50.USD","BK4563","LU1242518857.USD","LU0469268626.HKD","LU0052750758.USD","SG9999000475.SGD","DADA","LU1023057109.AUD","ONC","LU0502904849.HKD","BK1142","LU0880133367.SGD","FUTU","09988","NTES","PDD","LU0164865239.USD","LU0359201612.USD","06160","09618","BEKE","IE0034224299.USD","LU0164880469.USD","LU1267930227.SGD","VIPS","LU0329678337.USD","HK0000320264.USD","BK1161"],"gpt_icon":0},{"id":"2511661006","title":"【高瓴旗下HHLR Advisors披露四季度美股持仓 前十大重仓中概股占8席】高瓴旗下独立的、专注于二级市场投资的基金管理平台HHLR Advisors公布了截至2024年四季度末的美股持仓数据。数据显示，四季度HHLR Advisors前十大持仓中，中概股占据八席。百济神州、阿里巴巴仍为前两大重仓股，此外还有拼多多、网易、贝壳、唯品会、传奇生物和富途控股。持仓情况显示出HHLR Advisors对中国资产的持续聚焦。在HHLR Advisors四季度新进买入的4只股票中，2只为中概股，分别为声网和挚文集团（陌陌）。四季度HHLR Advisors增持了10只股票，其中4只为中概股，为京东、贝壳、富途控股和达达集团。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511661006","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511661006?lang=zh_cn&edition=full","pubTime":"2025-02-15 05:44","pubTimestamp":1739569478,"startTime":"0","endTime":"0","summary":"高瓴旗下独立的、专注于二级市场投资的基金管理平台HHLR Advisors公布了截至2024年四季度末的美股持仓数据。数据显示，四季度HHLR Advisors前十大持仓中，中概股占据八席。百济神州、阿里巴巴仍为前两大重仓股，此外还有拼多多、网易、贝壳、唯品会、传奇生物和富途控股。持仓情况显示出HHLR Advisors对中国资产的持续聚焦。在HHLR Advisors四季度新进买入的4只股票中，2只为中概股，分别为声网和挚文集团（陌陌）。四季度HHLR Advisors增持了10只股票，其中4只为中概股，为京东、贝壳、富途控股和达达集团。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15054448179795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0823038988.USD","BK4079","LU0106959298.USD","LU0417516738.SGD","89618","BK4527","NTES","LU0251143458.SGD","LU2039709279.SGD","MOMO","SG9999014674.SGD","09988","PDD","LU0540923850.HKD","LU1226287875.USD","LU1769817096.USD","BK4553","ONC","TTTN","LU1105468828.SGD","09618","IE00B3M56506.USD","06160","LU0047713382.USD","LU0890818403.SGD","BABA","VIPS","LU0502904849.HKD","DADA","LU0348735423.USD","LU1023057109.AUD","BK1531","688235","HK0000320264.USD","BK4524","BK4155","SG9999002463.SGD","LU0588545490.SGD","BEKE","LU1251922891.USD","LU1226288253.USD","LU0143863784.USD","LEGN","IE00B0JY6N72.USD","09999","FUTU","IE0008369823.USD","LU0516422952.EUR","LU0164865239.USD","JD"],"gpt_icon":0},{"id":"2509627744","title":"传奇生物盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509627744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509627744?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:33","pubTimestamp":1738852396,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时33分，传奇生物股票出现波动，股价快速下挫5.24%。截至发稿，该股报35.79美元/股，成交量6.2111万股，换手率0.03%，振幅7.70%。传奇生物股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3985.02%、351.31%、115.54%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Rani Therapeutics Holdings, Inc.、Relmada Therapeutics, Inc.，振幅分别为39.92%、18.06%、16.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223317a23bcecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223317a23bcecd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LEGN","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2509650804","title":"传奇生物盘中异动 早盘股价大涨5.15%报39.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509650804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509650804?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:01","pubTimestamp":1738684869,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时01分，传奇生物股票出现异动，股价大幅拉升5.15%。截至发稿，该股报39.23美元/股，成交量44.5843万股，换手率0.24%，振幅6.19%。传奇生物股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Quoin Pharmaceuticals Ltd涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1600.33%、916.89%、330.43%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为71.02%、49.88%、47.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000109abc23a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205000109abc23a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LEGN","BK4505","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2505488234","title":"传奇生物Carvykti大卖 9.63 亿美元：细胞治疗未来已来，如何解决普及难题？","url":"https://stock-news.laohu8.com/highlight/detail?id=2505488234","media":"21财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505488234?lang=zh_cn&edition=full","pubTime":"2025-01-24 15:34","pubTimestamp":1737704040,"startTime":"0","endTime":"0","summary":"公开数据显示，Carvykti凭借着92.7%的增长速度一马当先，成为了强生2024年创新制药业务中增长最为迅猛的产品，其全年销售额达9.63亿美元，比去年翻了近1倍。国内药物可及性仍待突破在Carvykti在海外市场大放异彩之际，本土药企的CAR-T药物还在经历无序竞争。复星国际联席CEO陈启宇日前在上海两会期间也表示，当下细胞治疗仍存在诸多问题待解决。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124154036987197e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124154036987197e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4588","LEGN","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":0.0486},{"period":"1month","weight":-0.1341},{"period":"3month","weight":0.0043},{"period":"6month","weight":-0.2349},{"period":"1year","weight":-0.3283},{"period":"ytd","weight":0.008}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"传奇生物科技有限公司是一家全球性的临床级生物制药公司，致力于肿瘤和其他适应症的新药的发现和开发。该公司的差异化技术、全球开发和制造战略及专业知识使其能够针对高未满足需求的适应症生成、测试和制造下一代细胞疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.018049},{"month":2,"riseRate":0.4,"avgChangeRate":0.004169},{"month":3,"riseRate":0.4,"avgChangeRate":-0.028053},{"month":4,"riseRate":0.6,"avgChangeRate":0.0627},{"month":5,"riseRate":0.5,"avgChangeRate":0.05248},{"month":6,"riseRate":1,"avgChangeRate":0.131481},{"month":7,"riseRate":0.6,"avgChangeRate":0.020473},{"month":8,"riseRate":0.2,"avgChangeRate":-0.044443},{"month":9,"riseRate":0.2,"avgChangeRate":-0.015767},{"month":10,"riseRate":0.4,"avgChangeRate":0.000994},{"month":11,"riseRate":0.4,"avgChangeRate":0.003857},{"month":12,"riseRate":0,"avgChangeRate":-0.083204}],"exchange":"NASDAQ","name":"传奇生物","nameEN":"Legend Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"传奇生物(LEGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供传奇生物(LEGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"传奇生物,LEGN,传奇生物股票,传奇生物股票老虎,传奇生物股票老虎国际,传奇生物行情,传奇生物股票行情,传奇生物股价,传奇生物股市,传奇生物股票价格,传奇生物股票交易,传奇生物股票购买,传奇生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"传奇生物(LEGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供传奇生物(LEGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}